Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Revenue

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,477 Cr₹1,559 Cr₹1,191 Cr₹951 Cr₹937 Cr

What is the latest Revenue of NEULAND LABORATORIES ?

The latest Revenue ratio of NEULAND LABORATORIES is ₹1,477 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,477 Cr
Mar2024₹1,559 Cr
Mar2023₹1,191 Cr
Mar2022₹951 Cr
Mar2021₹937 Cr

How is Revenue of NEULAND LABORATORIES Trending?

Years Revenue % Change
Mar2025 ₹1,477 Cr
-5.24
Mar2024 ₹1,559 Cr
30.84
Mar2023 ₹1,191 Cr
25.25
Mar2022 ₹951 Cr
1.51
Mar2021 ₹937 Cr -

Compare Revenue of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,911.1 Cr 4.4% 5.3% 16.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,185.0 Cr 3.5% 12.3% 5.6% Stock Analytics
DIVIS LABORATORIES ₹171,766.0 Cr 2.8% 7.2% 7.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,923.0 Cr 3.8% 12.1% 42.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,081.0 Cr 3% 9.1% 11.6% Stock Analytics
CIPLA ₹109,680.0 Cr 1.2% 2.8% -9.1% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

4.4%

5.3%

16.7%

SENSEX

-0.3%

-0.1%

8.3%


You may also like the below Video Courses